A 14-year-old with cystic fibrosis and a history of methicillin-resistant Staphylococcus aureus (MRSA) colonization develops hospital-acquired pneumonia with a fever of 39.2°C (102.6°F) and new infiltrates. Blood cultures grow MRSA. Why is daptomycin an unsuitable choice for treating the pneumonia component of this child’s illness?